Thursday, 29 June 2017

Generics News

  • Teva, Sun to pay $2.15 bn to Pfizer, Takeda to settle patent suit

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2013

    Singapore: Teva Pharmaceuticals Industries, Israel, and Sun Pharmaceutical Industries, India, are going to pay a combined amount of $2.15 billion to US-based Pfizer in order to settle a pat...Read more

  • Daiichi Sankyo collaborates with Maruishi Pharmaceutical

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 23 Jun, 2015

    Japan's Daiichi Sankyo Company and Maruishi Pharmaceutical Co. Ltd have signed an agreement to collaborate on the commercialization of the general anaesthesia analgesic, generic Remifentani...Read more

  • Teva to uphold Copaxone patent until May 2015

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013

    Singapore: Israel-based Teva Pharmaceuticals has recieved favourable response in England and Wales regarding the validity of the asserted claims of UK patent 762,888 relating to Copaxone (g...Read more

  • Pricing revision to cost Indian pharma $160 mn

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment | 25 Jun, 2013

    Mumbai: The pharmaceutical industry will be widely impacted after India's National Pharmaceutical Pricing Authority (NPPA) notified leading drug majors about ceiling prices. This will lead ...Read more

  • US antidepressant market slides down by 4%: report

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2013

    Singapore: Antidepressant market in US, that peaked at USD12 billion in 2008, has lost USD2.6 billion due to expired patents in the following years and currently stands at USD9.4 billion, d...Read more

  • Australia's Starpharma develops Zika-proof condoms for athletes ahead of Rio Olympics

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 17 May, 2016

    Australia's Starpharma Holdings Ltd and Ansell Limited have announced that the Australian Olympic team will be provided with antiviral Dual Protect VivaGel condoms for the upcoming Olympic ...Read more

  • Celgene settles litigation with India's Natco

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 28 Dec, 2015

    Singapore: US based Celgene has settled the litigation with India's Natco Pharma, Natco's US partner, Arrow International and Arrow's parent company, Watson Laboratories relating to patents...Read more

  • Self monitoring diabetes market to reach $358 mn

    Generics |  Analysis | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013

    Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly 200 million for the self monitoring of blood glucose (SMBG) market. ...Read more

  • Do India's bad quality drugs end up in Africa?

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2014

    Singapore: According to a research conducted by the National Bureau of Economic Research, some generic drugs sent from India to Africa are of lower quality, when compared to the same medici...Read more

  • Will Japan be able to reduce its generic drug prices?

    Generics |  Analysis | By Saptarshi Chaudhuri | 0 Comment | 21 May, 2013

    The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the US. Although it records annual sales of approximately $64.5 billion (...Read more

  • Daiichi Sankyo to commercialize AstraZeneca's nasal influenza vaccine in Japan

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015

    The global biologics research and development arm of AstraZeneca, MedImmune LLC, has entered into an exclusive license agreement with Daiichi Sankyo Company Ltd. to develop and commercializ...Read more

  • Mylan signs a settlement agreement with OSI Pharma

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013

    Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Japan's Astellas, Pfizer and Roche subsidiary Genentech that will resolv...Read more

  • India bans pain killer 36 years after the US did so

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2013

    New Delhi: The Indian health ministry has banned the sale of three medicines after learning about the health risks associated with them. Manufacture and sale of three drugs, painkiller Ana...Read more

  • Beximco Pharma enters EU market

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2013

    Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredients in Bangaldesh, has commenced export of its products to Europe. I...Read more

  • Glenmark's new generic gets FDA nod

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015

    Singapore: Glenmark Pharmaceuticals(Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for Drospirenone and Ethinyl Estradiol Tablets USP...Read more

  • Amneal pharma to acquire Actavis Australia's generic business

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2015

    Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Australia. The company has inked a binding letter of intent to acquire t...Read more

  • ANI pharma, IDT Australia to commercialize US generic drugs

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 18 Aug, 2015

    Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Australia a global generic manufacturer, to commercialize up to 18 previo...Read more

  • Brickell Biotech-Kaken Pharma to co-develop dermatology drug

    Generics |  News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2015

    Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development agreement for BBI-4000 with Kaken Pharmaceutical Co. Ltd., a top-tier...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls